Financial reports
ARS
2023 FY
Annual report to shareholders
25 Apr 24
10-K
2023 FY
Annual report
21 Feb 24
10-Q
2023 Q1
Quarterly report
1 Nov 23
10-Q
2023 Q1
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K
2021 FY
Annual report
21 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
10-Q
2022 Q1
Quarterly report
26 Apr 22
Current reports
8-K
Departure of Directors or Certain Officers
25 Apr 24
8-K
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
17 Apr 24
8-K
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
15 Apr 24
8-K
Exact Sciences Announces Fourth Quarter 2023 Results
21 Feb 24
8-K
Exact Sciences Announces Preliminary Fourth Quarter 2023 Results
8 Jan 24
8-K
Exact Sciences Announces Third-Quarter 2023 ResultsĀ Reports record revenue, delivers more than a million test results, raises full-year guidance
1 Nov 23
8-K
Exact Sciences Announces Second-Quarter 2023 ResultsĀ Reports record results, generates positive free cash flow, raises full-year guidance
1 Aug 23
8-K
Regulation FD Disclosure
21 Jun 23
8-K
Material Modifications to Rights of Security Holders
12 Jun 23
8-K
Exact Sciences Announces First Quarter 2023 ResultsĀ Reports record results, raises full-year guidance, accelerates path to positive free cash flow
9 May 23
Registration and prospectus
S-8
Registration of securities for employees
1 Aug 23
S-3ASR
Automatic shelf registration
25 May 23
424B7
Prospectus with selling stockholder info
17 Mar 23
S-8
Registration of securities for employees
2 Aug 22
424B7
Prospectus with selling stockholder info
2 May 22
424B7
Prospectus with selling stockholder info
10 Jan 22
424B7
Prospectus with selling stockholder info
7 Jun 21
424B7
Prospectus with selling stockholder info
5 Jan 21
S-8
Registration of securities for employees
5 Jan 21
424B2
Prospectus for primary offering
27 Oct 20
Proxies
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
PRE 14A
Preliminary proxy
14 Apr 23
DEFA14A
Additional proxy soliciting materials
20 May 22
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
Other
SEC STAFF
SEC staff action: Order
6 Apr 21
SEC STAFF
SEC staff action: Order
9 Mar 21
CT ORDER
Confidential treatment order
19 Feb 20
CT ORDER
Confidential treatment order
19 Feb 20
EFFECT
Notice of effectiveness
7 Oct 19
CT ORDER
Confidential treatment order
13 Aug 19
CT ORDER
Confidential treatment order
26 Feb 19
CT ORDER
Confidential treatment order
26 Feb 19
CT ORDER
Confidential treatment order
26 Feb 19
CT ORDER
Confidential treatment order
5 Nov 18
Ownership
4
Sarah Condella
3 Apr 24
4
Brian Baranick
3 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
4
Sarah Condella
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
28 Mar 24
4
JACOB A ORVILLE
4 Mar 24
4
DANIEL J LEVANGIE
4 Mar 24
4
James Herriott
4 Mar 24
4
Jeffrey Thomas Elliott
4 Mar 24